TrialArthritis research & therapy2016

A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study.

Dae Hyun Yoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.